Literature DB >> 26621715

Augmenting NMDA receptor signaling boosts experience-dependent neuroplasticity in the adult human brain.

Jennifer K Forsyth1, Peter Bachman2, Daniel H Mathalon3, Brian J Roach4, Robert F Asarnow5.   

Abstract

Experience-dependent plasticity is a fundamental property of the brain. It is critical for everyday function, is impaired in a range of neurological and psychiatric disorders, and frequently depends on long-term potentiation (LTP). Preclinical studies suggest that augmenting N-methyl-d-aspartate receptor (NMDAR) signaling may promote experience-dependent plasticity; however, a lack of noninvasive methods has limited our ability to test this idea in humans until recently. We examined the effects of enhancing NMDAR signaling using d-cycloserine (DCS) on a recently developed LTP EEG paradigm that uses high-frequency visual stimulation (HFvS) to induce neural potentiation in visual cortex neurons, as well as on three cognitive tasks: a weather prediction task (WPT), an information integration task (IIT), and a n-back task. The WPT and IIT are learning tasks that require practice with feedback to reach optimal performance. The n-back assesses working memory. Healthy adults were randomized to receive DCS (100 mg; n = 32) or placebo (n = 33); groups were similar in IQ and demographic characteristics. Participants who received DCS showed enhanced potentiation of neural responses following repetitive HFvS, as well as enhanced performance on the WPT and IIT. Groups did not differ on the n-back. Augmenting NMDAR signaling using DCS therefore enhanced activity-dependent plasticity in human adults, as demonstrated by lasting enhancement of neural potentiation following repetitive HFvS and accelerated acquisition of two learning tasks. Results highlight the utility of considering cellular mechanisms underlying distinct cognitive functions when investigating potential cognitive enhancers.

Entities:  

Keywords:  NMDA receptor; d-cycloserine; learning; long-term potentiation; neuroplasticity

Mesh:

Substances:

Year:  2015        PMID: 26621715      PMCID: PMC4687562          DOI: 10.1073/pnas.1509262112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  54 in total

1.  NMDA receptor-dependent synaptic reinforcement as a crucial process for memory consolidation.

Authors:  E Shimizu; Y P Tang; C Rampon; J Z Tsien
Journal:  Science       Date:  2000-11-10       Impact factor: 47.728

2.  NMDA receptor-dependent long-term potentiation and long-term depression (LTP/LTD).

Authors:  Christian Lüscher; Robert C Malenka
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-06-01       Impact factor: 10.005

Review 3.  The neurobiology of category learning.

Authors:  F Gregory Ashby; Brian J Spiering
Journal:  Behav Cogn Neurosci Rev       Date:  2004-06

Review 4.  Basal ganglia and dopamine contributions to probabilistic category learning.

Authors:  D Shohamy; C E Myers; J Kalanithi; M A Gluck
Journal:  Neurosci Biobehav Rev       Date:  2007-08-10       Impact factor: 8.989

5.  Characterization of the interactive effects of glycine and D-cycloserine in men: further evidence for enhanced NMDA receptor function associated with human alcohol dependence.

Authors:  John H Krystal; Ismene L Petrakis; Diana Limoncelli; Susan Krasnicki Nappi; Louis Trevisan; Brian Pittman; Deepak C D'Souza; Raymond F Suckow
Journal:  Neuropsychopharmacology       Date:  2010-12-01       Impact factor: 7.853

6.  A new method for off-line removal of ocular artifact.

Authors:  G Gratton; M G Coles; E Donchin
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1983-04

7.  Rapid visual stimulation induces N-methyl-D-aspartate receptor-dependent sensory long-term potentiation in the rat cortex.

Authors:  Wesley C Clapp; Michael J Eckert; Tim J Teyler; Wickliffe C Abraham
Journal:  Neuroreport       Date:  2006-04-03       Impact factor: 1.837

8.  Roles of endocannabinoids in heterosynaptic long-term depression of excitatory synaptic transmission in visual cortex of young mice.

Authors:  Yan Huang; Hiroki Yasuda; Abdolrahman Sarihi; Tadaharu Tsumoto
Journal:  J Neurosci       Date:  2008-07-09       Impact factor: 6.167

9.  D-cycloserine facilitates synaptic plasticity but impairs glutamatergic neurotransmission in rat hippocampal slices.

Authors:  E Rouaud; J-M Billard
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

10.  The NMDA agonist D-cycloserine facilitates fear memory consolidation in humans.

Authors:  Raffael Kalisch; Beatrice Holt; Predrag Petrovic; Benedetto De Martino; Stefan Klöppel; Christian Büchel; Raymond J Dolan
Journal:  Cereb Cortex       Date:  2008-05-13       Impact factor: 5.357

View more
  19 in total

Review 1.  Mapping the Consequences of Impaired Synaptic Plasticity in Schizophrenia through Development: An Integrative Model for Diverse Clinical Features.

Authors:  Jennifer K Forsyth; David A Lewis
Journal:  Trends Cogn Sci       Date:  2017-07-25       Impact factor: 20.229

2.  Dose-Related Target Occupancy and Effects on Circuitry, Behavior, and Neuroplasticity of the Glycine Transporter-1 Inhibitor PF-03463275 in Healthy and Schizophrenia Subjects.

Authors:  Deepak Cyril D'Souza; Richard E Carson; Naomi Driesen; Jason Johannesen; Mohini Ranganathan; John H Krystal
Journal:  Biol Psychiatry       Date:  2018-01-31       Impact factor: 13.382

3.  Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine.

Authors:  Jennifer K Forsyth; Peter Bachman; Daniel H Mathalon; Brian J Roach; Elissa Ye; Robert F Asarnow
Journal:  Schizophr Bull       Date:  2017-09-01       Impact factor: 9.306

4.  Intra-hippocampal D-cycloserine rescues decreased social memory, spatial learning reversal, and synaptophysin levels in aged rats.

Authors:  Marta Portero-Tresserra; Margarita Martí-Nicolovius; Mireia Tarrés-Gatius; Ana Candalija; Gemma Guillazo-Blanch; Anna Vale-Martínez
Journal:  Psychopharmacology (Berl)       Date:  2018-02-28       Impact factor: 4.530

Review 5.  Brain is modulated by neuronal plasticity during postnatal development.

Authors:  Masoumeh Kourosh-Arami; Nasrin Hosseini; Alireza Komaki
Journal:  J Physiol Sci       Date:  2021-11-17       Impact factor: 2.781

6.  AGING-ASSOCIATED COGNITIVE DECLINE IS REVERSED BY D-SERINE SUPPLEMENTATION.

Authors:  L Nava-Gómez; I Calero-Vargas; F Higinio-Rodríguez; B Vázquez-Prieto; R Olivares-Moreno; J Ortiz-Retana; P Aranda; N Hernández-Chan; G Rojas-Piloni; S Alcauter; M López-Hidalgo
Journal:  eNeuro       Date:  2022-05-18

7.  Glutamatergic metabolites are associated with visual plasticity in humans.

Authors:  S Andrea Wijtenburg; Jeffrey West; Stephanie A Korenic; Franchesca Kuhney; Frank E Gaston; Hongji Chen; Meredith Roberts; Peter Kochunov; L Elliot Hong; Laura M Rowland
Journal:  Neurosci Lett       Date:  2017-02-10       Impact factor: 3.046

8.  Visual cortical plasticity and the risk for psychosis: An interim analysis of the North American Prodrome Longitudinal Study.

Authors:  Michael S Jacob; Brian J Roach; Holly K Hamilton; Ricardo E Carrión; Aysenil Belger; Erica Duncan; Jason Johannesen; Matcheri Keshavan; Sandra Loo; Margaret Niznikiewicz; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; William Stone; Ming Tsuang; Elaine F Walker; Scott W Woods; Daniel H Mathalon
Journal:  Schizophr Res       Date:  2021-03-02       Impact factor: 4.939

9.  Exploring the Use of Sensorial LTP/LTD-Like Stimulation to Modulate Human Performance for Complex Visual Stimuli.

Authors:  Felipe Pegado; Hendrik Vankrunkelsven; Jean Steyaert; Bart Boets; Hans Op de Beeck
Journal:  PLoS One       Date:  2016-06-24       Impact factor: 3.240

10.  The NMDA receptor partial agonist d-cycloserine does not enhance motor learning.

Authors:  Jan Günthner; Jacqueline Scholl; Elisa Favaron; Catherine J Harmer; Heidi Johansen-Berg; Andrea Reinecke
Journal:  J Psychopharmacol       Date:  2016-07-19       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.